linsidomine has been researched along with sq-23377 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alam, AS; Datta, HK; Hecker, M; Lidbury, PS; MacIntyre, I; Moonga, BS; Vane, JR; Zaidi, M | 1 |
Akaike, A; Asano, Y; Honda, Y; Kashii, S; Nishida, A; Sato, S; Yamauchi, T; Yasuyoshi, H; Zhang, S | 1 |
2 other study(ies) available for linsidomine and sq-23377
Article | Year |
---|---|
Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.
Topics: Animals; Animals, Newborn; Bone Resorption; Calcitonin; Calcium; Cell Membrane; Cells, Cultured; Cyclic GMP; Cytosol; Dibutyryl Cyclic GMP; Ionomycin; Kinetics; Molsidomine; Nitric Oxide; Osteoclasts; Rats; Rats, Inbred Strains; Vasodilator Agents | 1991 |
Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons.
Topics: Adrenergic beta-Antagonists; Animals; Bradykinin; Bradykinin Receptor Antagonists; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Glutamic Acid; Ionomycin; Molsidomine; Neurons; Neuroprotective Agents; Nitroprusside; Rats; Rats, Wistar; Receptor, Bradykinin B2; Receptors, Bradykinin; Retina; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2000 |